Combined therapy of B16(F10) murine melanoma using E. coli cytosine deaminase gene and murine interleukin-4 gene

Neoplasma

Volumn 45, Issue 5, 1998, Pages 305-311

  Missol Kolka, E ^a   Sochanik, A ^a   Szala, S ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Cationic liposomes; Combined therapy; E. coli cytosine deaminase; Gene therapy; Interleukin 4; Suicide genes

Indexed keywords

CYTOSINE DEAMINASE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; INTERLEUKIN 4; LIPOSOME;

ADOLESCENT; ARTICLE; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; EXPERIMENTAL NEOPLASM; GENE THERAPY; MELANOMA; MOUSE; NONHUMAN; SUICIDE GENE;

EID: 0032421343     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. BLAESE, R.M., ISCHII-MORITA, H., MULLEN, C., RAMSEY, J., RAM, Z., OLDFIELD, E., CULVER, K.: In situ delivery of suicide genes for cancer treatment. Eur. J. Cancer, 30A, 1994, 1190-1193.
2. BORRELLI, E., HEYMAN, R., HSI, M., EVANS, R.M.: Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA, 85, 1988, 7572-7576.
3. CASTLEDEN, S.A., CHONG, H., GARCIA-RIBAS, I., MELCHER, A.A., HUTCHINSON, G., ROBERTS, B., HART, I.R., VILE, R.G.: A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSV-tk of cytokine expression in a murine melanoma model. Hum. Gene Ther., 8, 1997, 2087-2102.
4. CHEN, S-H., KOSAI, K-I., XU, B., NGUYEN, K.P., CONTANT, CH., FINEGOLD, M.J., RICH, S.S., WOO, S.L.C.: Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: Sustained antitumor immunity prolongs animal survival. Cancer Res., 56, 1996, 3758-3762.
5. FORNI, G., CAVALLO, F., CONSALVO, M., ALLIONE, A., DELLABONA, P., CASORATI, G., GIOVARELLI, M.: Molecular approaches to cancer immunotherapy. Cytokines Mol. Ther., 1, 1995, 225-248.
6. FREEMAN, S.M., WHARTENBY, K.A., FREEMAN, J.L., ABBOUD, C.N., MARROGI, A.J.: In situ use of suicide genes for cancer therapy. Semin. Oncol., 23, 1996, 31-45.
7. GAO, X., HUANG, L.: Cationic liposome-mediated gene transfer. Gene Then, 2, 1995, 710-722.
8. GOLUMBEK, P.T., LAZENBY, A.J., LEVITSKY, H.I., JAFFEE, L.M., KARASUYAMA, M., BAKER, M., PARDOLL, D.M.: Treatment of established renal cancer by tumor cells engineered to secrete Interleukin-4. Science, 254, 1991, 713-716.
9. HOLLINGSWORTH, S.J., DARLING, D., GAKEN, J., HIRST, W., PATEL, P., KUIPER, M., TOWNER, P., HUMPHREYS, S., FARZANEH, F., MUFTI, G.J.: The effect of combined expression of Interleukin-2 and Interleukin-4 on the tumorigenicity and treatment of B16(F10) melanoma. Br. J. Cancer, 74, 1996, 6-15.
10. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., DAVIS, S.T., GOOD, S.S.: Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effect when only a small percentage of tumor cells expresses cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91, 1994, 8302-8306.